Bristol-Myers Squibb Co (MIL:1BMY) Short Interest


MIL:1BMY Bristol-Myers Squibb Co MIL:1BMY
49 GF Score
Price €50.56
GF Value €48.51
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MIL:1BMY vs PFE, GILD, AMGN: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Short Interest falls into.


MIL:1BMY
49GF Score
Bristol-Myers Squibb Co MIL:1BMY
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bristol-Myers Squibb Co (MIL:1BMY) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of €50.56 is trading 4.2% above its estimated GF Value™ of €48.51. GuruFocus considers Bristol-Myers Squibb Co to be Fairly Valued.

Key valuation signals for MIL:1BMY:

  • Short Interest:
  • GF Value™: €48.51 vs. price of €50.56 (4.2% above fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the MIL:1BMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
49GF Score

Get the complete analysis for MIL:1BMY

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€50.56
Price
€48.51
GF Value